Glycylpressin (Terlipressin Acetate)

Glycylpressin is indicated for specific acute conditions that involve severe bleeding or renal dysfunction related to liver disease.

• Management of acute variceal bleeding in patients with portal hypertension.
• Treatment of hepatorenal syndrome type 1 in cirrhotic patients.
• Adjunctive therapy to control hemorrhage during endoscopic procedures for esophageal varices.
• Supportive use in selected cases of refractory hypotension where vasoconstriction is required.
• Temporary stabilization of hemodynamics in patients undergoing liver transplantation when severe vasodilation is present.
• Off‑label consideration for septic shock unresponsive to conventional vasopressors, under specialist supervision.

The safety profile of Glycylpressin reflects its vasoconstrictive activity; side effects are reported across a range of frequencies, from mild and transient to potentially life‑threatening. Patients receiving the drug are monitored for cardiovascular and renal responses.

Common

• Headache
• Nausea or vomiting
• Abdominal discomfort or cramps
• Flushing or warmth at the infusion site
• Dizziness or light‑headedness
• Transient tachycardia

Serious

• Severe hypertension or hypertensive crisis
• Cardiac arrhythmias, including atrial or ventricular ectopy
• Ischemic complications such as myocardial infarction, limb ischemia, or bowel infarction
• Acute renal failure or worsening of existing renal impairment
• Pulmonary edema
• Severe electrolyte disturbances (e.g., hyponatremia)

When prescribing Glycylpressin, clinicians should evaluate patient history and monitor for conditions that may increase the risk of adverse events.

• Known hypersensitivity to terlipressin, vasopressin analogs, or any excipients.
• Uncontrolled hypertension or severe cardiovascular disease.
• Active coronary artery disease or recent myocardial infarction.
• Severe peripheral vascular disease or risk of limb ischemia.
• Pregnancy and lactation status unknown; use only if potential benefit justifies risk.
• Concomitant use of other potent vasoconstrictors.
• Impaired renal function requiring dose adjustment or close monitoring.

Glycylpressin may interact with other agents that affect vascular tone, cardiac rhythm, or renal function; awareness of these interactions helps minimize complications.

Avoid

• Other vasopressors or sympathomimetic agents (e.g., norepinephrine, phenylephrine) due to additive vasoconstriction.
• Monoamine oxidase inhibitors combined with certain serotonergic drugs that could increase risk of hypertension.
• Concomitant use with potent vasodilators (e.g., nitroglycerin) that may counteract therapeutic effect.

Use with caution

• Beta‑blockers, which may mask tachycardia.
• Diuretics, especially loop diuretics, that can exacerbate electrolyte imbalances.
• Anticoagulants or antiplatelet agents, as severe hypertension may increase bleeding risk.